|
|
|
Practice Partners in Healthcare, based in Birmingham, Alabama, develops, invests in and manages ambulatory surgery centers ("ASCs") in partnership with leading surgeons and physicians, primarily in the Southeast and Midwest. The Company's business model is to identify groups of physicians performing ASC eligible surgeries at hospitals and perhaps other ASCs who are interested in coming together to create and own their own ASC. Based on data relating to reimbursement and case mix, along with input from the physicians, Practice Partners develops the appropriate design and specifications for the proposed ASC and oversees its development and construction. Practice Partners typically "rolls" its development fee into a minority equity interest in the ASC in addition to providing management services. Practice Partners will also selectively invest in existing ASCs where it believes it can improve operations and/or assist with re-syndication.
|
|
|
Access Closure, based in Mountain View, California, is a privately held medical device company that is pioneering innovative access site management products designed to address the complex challenge of vascular closure during interventional and diagnostic procedures. Access Closure’s first product, the Mynx vascular closure device, is based on a conformable, water soluble polyethylene glycol (PEG) extravascular sealant that instantly expands in the tissue tract by rapidly absorbing blood and subcutaneous fluids. The sealant then dissolves within 30 days, leaving nothing behind but a healed artery.
|
|
|
Paradigm Spine, based in New York, New York is a global provider of indication specific non-fusion spinal implants that are aimed at reducing pain and preserving motion. Paradigm Spine's devices are designed for use by orthopedic spine surgeons and neurosurgeons to treat degenerative (age-related) and adolescent deformity spinal diseases.
|
|
|
ApaTech, based in London, England, specialises in producing synthetic bone repair material. It has operations in London, England, Foxborough, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 21 countries around the world. The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company's leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive and osteo-stimulatory activities that accelerate bone healing. ApaTech was recognized as Britain's fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review. Additionally ApaTech won the coveted 2008 Fast Track Research and Development award for the exceptional contribution scientific innovation has played in the company's success.
|
|
|
Corindus, based in Natick, Massachusetts, is a global leader in the development of precision vascular robotic systems designed specifically for percutaneous applications. The company's Corpath system enables the interventional physician to perform catheterization procedures with precision from a remote location, beyond the radiation zone. Compatible with state-of-the-art cardiology products and cath lab imaging technologies, the Corindus technology mechanically maneuvers devices through patients' vasculature as specified by the physician at a remote workstation. The proprietary technology utilizes physician fluoroscopic control similar to routine practice to allow maneuvering and torquing of cath lab devices. The system will easily integrate into an existing cath lab room with simple installation and little downtime.
|
|
|
